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To determine the mode of disulphide bond formation in conotoxin GI, a tridecapeptide amide with 4 Cys 
residues, all 3 of its peptides having different modes of disulphide-bond formation were synthesized by 
solution procedure using selectively removable protective groups at the Cys residues. After deprotection 
with HF, one pair of acetamidomethyl groups was left unremoved, and then two sets of disulphide bonds 
were formed selectively. The toxic potency in mice of one product was comparable with that reported for 
native conotoxin GI and was almost IO-fold as high as that of the other two products. The toxicity of the 
native toxin reportedly is not regenerated upon reduction and reoxidation, but this study showed that the 
most toxic product was the most readily formed one. 
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1. INTRODUCTION 
Conotoxins are peptidic neurotoxins isolated 
from the venom of the marine snail Conus geog- 
raphus and cause postsynaptic inhibition at the 
vertebrate neuromuscular junction [ 11. Although 
the peptides are relatively small, consisting of 13- 
15 amino acids, their potency on a molar basis is of 
the same order of activity as tetrodotoxin or the 
most potent scorpion neurotoxins. Three peptides, 
named conotoxin GI, GIA and GII, were isolated 
from the venom and then the amino acid se- 
quences were elucidated (fig.1) by Gray et al. in 
1981 121. These toxins are reported to be equally 
sensitive to disulphide breaking reagents such as 
borohydride or mercaptoethanol, but the mode of 
the disulphide bond formation is not yet known 
except for the fact that these peptides exist in the 
monomeric form [ 1,2]. Once these disulphide 
bonds are reduced, the toxicity is not regenerated 
by reoxidation [2]. From this finding, the second- 
ary structure of the native toxin has been thought 
to be thermodynamically unstable. As two di- 
sulphide bonds are formed in each molecule, 3 dif- 
ferent modes of disulphide bond formation can be 
considered for each peptide as indicated by types 
A, B and C in fig.2. This study dealt with the selec- 
tive synthesis of all 3 types of peptides having the 
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Conotoxin GI: G1u-Cys-Cys-Asn-Pro-Ala-Cys-Gly-Arg-His-Tyr-Ser-Cys-N~~ 
Conotoxin GIA: Glu-Cys-Cys-Asn-Pro-AIa-Cys-GIy-Arg-Bis-Tyr-Ser-Cys-Gly-Lys-NH~ 
Conotoxin GII: Glu-Cys-Cys-His-Pro-Ala-Cys-Gly-Lys-His-Phe-Ser-Cys-NH~ 
Fig. 1. The primary structure of conotoxins. 
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Type A: --C:s-c:S -:s----------ICys-iiH2 
I I Type B: --cys-c$s- ps-----c;s-Nl~2 
I 
Type C: ---xys-cys --c;------C?s-N”, 
Fig.2. Three possible modes of disulphide bond forma- 
tion in conotoxin GI. 
sequence proposed for conotoxin GI, in order to 
determine which secondary structure should be as- 
signed to the native toxin. 
2. EXPERIMENTAL 
Syntheses of these peptides were carried out by 
the conventional solution procedure. The Boc 
group was used for temporary protection of (Y- 
amino groups during the synthesis and was re- 
moved by treatment with trifluoroacetic acid. The 
following protective groups were used for the side- 
chain functional groups: benzyl (Bzl) for Ser or 
Glu; 2,6-dichlorobenzyl (Clz-Bzl) for Tyr; tosyl 
(Tos) for Arg or His; acetamidomethyl (Acm); and 
4-methylbenzyl (4-MeBzl) for Cys. The terminal 
amino group of the peptide was protected by ben- 
zyloxycarbonyl (Z). The Tos group attached to His 
was removed by treatment with l-hydroxybenzo- 
triazole (HOBT) immediately after incorporation 
of the His (Tos) residue into the peptides. Each 
amino acid or segment was coupled by the active 
ester procedure or using a water-soluble carbo- 
diimide (WSCI), I-ethyl-3-(3-dimethylamino- 
propyl)-carbodiimide, in the presence of HOBT. 
A 
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Fig.4. HPLC profiles of 3 different types of conotoxin 
GI peptides: column,nucleosil SC18 (150 X 4 mm id.); 
solvent, 12% acetonitrile in 10 mM phosphate buffer 
(pH 2.6) containing 50 mM Na2S04; detection, 210 nm; 
flowrate, 1 ml/min. 
Each peptide was assembled from 3 segments as 
shown in tig.3. The final protected peptide was 
treated with HF at 0°C in the presence of anisole 
[3], and the product, which contained 2 free Cys 
residues and 2 Cys (Acm) residues, was oxidized 
Z-Glu(OBzl)-Cys(Rl)-Cys(R2)-Asn-Pro-OH 
Boc-Ala-Cys(R3)-Gly-OH 
Boc-Arg(Tos)-His-Tyr(C 
Z-Glu(OBzl)-Cys(Rl)-Cys(R2)-Asn-Pro-Ala-Cys(R3)-Gly-Arg(Tos)-His- 
Tyr(C12Bzl)-Ser(Bzl)-Cys(R$ -NH2 
Fig.3. Synthesis of protected peptides. Type A: RI, R2 = Acm; R3, R4 = 4-MeBzl. Type B: RI, R3 = Acm; RI, R4 = 
4-MeBzl. Type C: R2, R3 = Acm; RI, R4 = 4-MeBzl. 
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using the ferricyanide procedure [4] in 1 M am- 
monium acetate solution in the presence of 8 M 
urea at pH 6.9. The crude product, which was ex- 
pected to contain 1 disulphide bond and 2 Cys 
(Acm) residues, was purified on Sephadex LH-20 
using 0.5 M acetic acid as the solvent, and then 
dissolved in methanol-water (4: 1) in the presence 
of 1.5 equiv. of HCl. The solution was stirred into 
a 0.1 M solution of iodine ( - 15 equiv.) in meth- 
anol to form the second disulphide bond [5]. After 
10 min stirring, the reaction was stopped by adding 
a solution of ascorbic acid in citrate buffer at pH 5. 
Final purification of the product was achieved by 
reverse phase HPLC on a column of Nucleosil 
5Cts. Starting from 500 mg each of the original 
protected peptide, yields of the purified products 
were 31 mg (14.5%) for type A peptide, 45 mg 
(24.5%) for type B and 10 mg (4.0%) for type C. 
The homogeneity of each product was confirmed 
by HPLC as shown in fig.4 and by TLC on a cel- 
lulose plate. All 3 products gave reasonable values 
for the recovery and the ratio of the component 
amino acids after acid hydrolysis. The stability of 
each peptide under various conditions was tested 
using the HPLC system. Each peptide thus far syn- 
thesized was dissolved in water, and the toxicity 
was tested by intraperitoneal injection into mice as 
in [ 11. 
3. RESULTS AND DISCUSSION 
No specific problem was encountered uring the 
synthesis of these peptides except for control of the 
stability of the thiol groups or disulphide bonds 
formed. Using HPLC as a monitor, it was con- 
firmed that the thiol groups formed were relatively 
stable under acidic conditions, and the second di- 
sulphide bond was formed without interference 
from the pre-formed disulphide bond (as in [S]) 
provided that the reaction mixture was processed 
within a short period. All 3 synthetic peptides with 
different secondary structures were also relatively 
stable in water under neutral or slightly acidic con- 
ditions. However, once the disulphide bonds were 
reduced and then freely oxidized, all 3 peptides, 
type A-C, showed the same tendency to generate 
the type B peptide in a > 50% yield. 
The toxicity test in mice revealed that 13 pg/kg 
of the type B peptide was enough to cause a flaccid 
muscle paralysis followed by the death of the ani- 
mals within 20 min; the potency was comparable 
with a reported value for native conotoxin (L&O 
= 12 pg/kg) [l]. Almost the same result was ob- 
served with type A or C peptide when lo-times or 
higher doses were given to mice. These findings 
clearly indicate that the most readily forming con- 
former is the most potent one in the biological 
activity. This result completely conflicts with pre- 
vious findings that once reduction has occurred 
with this native toxin, reoxidation does not result 
in reactivation of the toxicity [2]. The discrepancy 
must be solved by comparing the natural and syn- 
thetic peptides under the same experimental con- 
ditions. Applying the present experimental ap- 
proach, we may be able to shed more light not 
only on the structure-activity relationship of con- 
otoxins but also on the mechanism of postsynaptic 
inhibition at the neuromuscular junction, 
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